Facilitated By

San Antonio Medical Foundation

News

  • Intensity Therapeutics, Inc. to Present Two Posters at the 2025 - GuruFocus

    ... Biotechnology NAS:INTS. Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer Symposium. Author's Avatar.

  • NiKang Therapeutics Presents Discovery of NKT5097, a First-in-Class, Highly Potent and ...

    ... San Antonio Breast Cancer Symposium (SABCS 2025) being held December 9 ... Biotechnology. NiKang Therapeutics Inc. Logo. NiKang Therapeutics ...

  • Pfizer Builds Case for Tukysa as 'New Standard Regimen' in First-Line Metastatic Breast Cancer

    Results, announced Wednesday and presented at the 48th San Antonio Breast Cancer Symposium (SABCS), showed the Tukysa-based combo cut the risk of ...

  • NiKang Therapeutics Presents Discovery of NKT5097, a First-in-Class, Highly ... - Rutland Herald

    ... San Antonio Breast Cancer Symposium (SABCS 2025) being held December 9 ... NiKang Therapeutics is a clinical-stage biotech company focused on ...

  • Wobble Genomics To Present New Data At SABCS Confirming Platform's Ability To ... - Morningstar

    EDINBURGH, Scotland, Dec. 11, 2025 /PRNewswire/ -- Wobble Genomics, a biotechnology ... San Antonio, Texas. The data demonstrates the ability to ...